Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-i...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Brady, James A Winchester, James F Davankov, Vadim Tsyuruoa, Maria Pavlova, Ludmila Norris, Frank M Quartararo, Jr, Peter J Salsberg, Jamie A |
| description | Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07556768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07556768</sourcerecordid><originalsourceid>FETCH-uspatents_grants_075567683</originalsourceid><addsrcrecordid>eNqNjjEKwkAQRdNYiHqHOYABQZJYK4oHsJdNdjYZ2N0JO5NALuGZTdDGzuq__3nFX2evM3HDoTdKtUewOFKDsgeZRDHMYKKFgNqxFXCcIKEdGooteBzRC7CDPnFO0XkTglFOE8yaiUq_oyiFwS8sixDQ0qdQBO0Qas9st9nKGS-4--Ymg9v1cbnng8wXMao822SWOFRFUVbl6fiH8gbPS1A9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood</title><source>USPTO Issued Patents</source><creator>Brady, James A ; Winchester, James F ; Davankov, Vadim ; Tsyuruoa, Maria ; Pavlova, Ludmila ; Norris, Frank M ; Quartararo, Jr, Peter J ; Salsberg, Jamie A</creator><creatorcontrib>Brady, James A ; Winchester, James F ; Davankov, Vadim ; Tsyuruoa, Maria ; Pavlova, Ludmila ; Norris, Frank M ; Quartararo, Jr, Peter J ; Salsberg, Jamie A ; MedaSorb Corporation</creatorcontrib><description>Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.</description><language>eng</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7556768$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7556768$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Brady, James A</creatorcontrib><creatorcontrib>Winchester, James F</creatorcontrib><creatorcontrib>Davankov, Vadim</creatorcontrib><creatorcontrib>Tsyuruoa, Maria</creatorcontrib><creatorcontrib>Pavlova, Ludmila</creatorcontrib><creatorcontrib>Norris, Frank M</creatorcontrib><creatorcontrib>Quartararo, Jr, Peter J</creatorcontrib><creatorcontrib>Salsberg, Jamie A</creatorcontrib><creatorcontrib>MedaSorb Corporation</creatorcontrib><title>Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood</title><description>Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjjEKwkAQRdNYiHqHOYABQZJYK4oHsJdNdjYZ2N0JO5NALuGZTdDGzuq__3nFX2evM3HDoTdKtUewOFKDsgeZRDHMYKKFgNqxFXCcIKEdGooteBzRC7CDPnFO0XkTglFOE8yaiUq_oyiFwS8sixDQ0qdQBO0Qas9st9nKGS-4--Ymg9v1cbnng8wXMao822SWOFRFUVbl6fiH8gbPS1A9</recordid><startdate>20090707</startdate><enddate>20090707</enddate><creator>Brady, James A</creator><creator>Winchester, James F</creator><creator>Davankov, Vadim</creator><creator>Tsyuruoa, Maria</creator><creator>Pavlova, Ludmila</creator><creator>Norris, Frank M</creator><creator>Quartararo, Jr, Peter J</creator><creator>Salsberg, Jamie A</creator><scope>EFH</scope></search><sort><creationdate>20090707</creationdate><title>Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood</title><author>Brady, James A ; Winchester, James F ; Davankov, Vadim ; Tsyuruoa, Maria ; Pavlova, Ludmila ; Norris, Frank M ; Quartararo, Jr, Peter J ; Salsberg, Jamie A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_075567683</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Brady, James A</creatorcontrib><creatorcontrib>Winchester, James F</creatorcontrib><creatorcontrib>Davankov, Vadim</creatorcontrib><creatorcontrib>Tsyuruoa, Maria</creatorcontrib><creatorcontrib>Pavlova, Ludmila</creatorcontrib><creatorcontrib>Norris, Frank M</creatorcontrib><creatorcontrib>Quartararo, Jr, Peter J</creatorcontrib><creatorcontrib>Salsberg, Jamie A</creatorcontrib><creatorcontrib>MedaSorb Corporation</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Brady, James A</au><au>Winchester, James F</au><au>Davankov, Vadim</au><au>Tsyuruoa, Maria</au><au>Pavlova, Ludmila</au><au>Norris, Frank M</au><au>Quartararo, Jr, Peter J</au><au>Salsberg, Jamie A</au><aucorp>MedaSorb Corporation</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood</title><date>2009-07-07</date><risdate>2009</risdate><abstract>Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07556768 |
| source | USPTO Issued Patents |
| title | Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T17%3A08%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Brady,%20James%20A&rft.aucorp=MedaSorb%20Corporation&rft.date=2009-07-07&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07556768%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |